Transvaginal cervical measurement and fetal fibronectin testing, used separately or together, do not adequately predict preterm birth and should not be used in routine care of nulliparous women, according to a study in JAMA. Read more
© 2020 HealthCom Media
All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder